Nebula Research & Development LLC
- SEC CIK
- 0001792635
- Latest filing
- May 15, 2026
ITCI holding history
Intra-Cellular Therapies, Inc. in every 13F filed by Nebula Research & Development LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ITCI overviewAll 13F holders of ITCIFull Q1 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −31,781−100.0% | Sold out | Holders |
| Q4 2024 | 31,781 | $2.65M | 0.3% | +9,740+44.2% | Added | Holders |
| Q3 2024 | 22,041 | $1.61M | 0.2% | −11,631−34.5% | Reduced | Holders |
| Q2 2024 | 33,672 | $2.31M | 0.4% | +33,672 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −8,631−100.0% | Sold out | Holders |
| Q4 2023 | 8,631 | $618.2K | 0.2% | +2,166+33.5% | Added | Holders |
| Q3 2023 | 6,465 | $336.8K | 0.2% | +6,465 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −3,960−100.0% | Sold out | Holders |
| Q1 2023 | 3,960 | $214.4K | 0.4% | – | No prior filing | Holders |